https://insights.panaceainc.com/wp-content/uploads/2018/12/stethoscope-on-chart-graph-paper-finance-account-statistic-analytic-picture-id1288981181.jpg400566Panacea Insightshttps://insights.panaceainc.com/wp-content/uploads/2019/11/logo-2.pngPanacea Insights2022-03-24 10:41:372023-06-09 12:50:53Panacea to Showcase Auditing Technology at the Annual HCCA Conference
The 2022 Final Rule defines split (or shared) visits as evaluation and management (E&M) visits in the facility setting that are performed in part by both the physician and a non-physician practitioner (NPP) who are in the same group, in accordance with applicable laws and regulations.
On Jan. 1, 2017, the Centers for Medicare & Medicaid Services (CMS) and Medicare Administrative Contractors (MACs) began requiring the use of the JW modifier. The JW modifier is appended […]
https://insights.panaceainc.com/wp-content/uploads/2021/07/male-medicine-doctor-hands-hold-jar-of-pills-picture-id542314172.jpg400566Panacea Insightshttps://insights.panaceainc.com/wp-content/uploads/2019/11/logo-2.pngPanacea Insights2021-07-14 13:55:202024-01-08 15:20:38Document Your Leftovers: The JW Modifier and How to Use It
In today’s era of intense public scrutiny on medical costs, what’s your pricing strategy? Does it pass the test of fairness and accuracy, without sacrificing revenue objectives? In this article, Panacea’s experts share their recommendations on where to start.
Do you and your team have a good process to readily identify and bill appropriately for self-administered drugs? The Centers for Medicare & Medicaid Services (CMS) has had a longstanding […]
Compliance plans are critical to making sure your organization is mitigating risk. The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) recommends that you audit […]
The chaos and confusion fomented throughout the American healthcare industry by the continuing COVID-19 pandemic has been bad enough in of itself – but when coders found themselves unable to […]
Following the recent unveiling by federal officials of the 2021 Outpatient Prospective Payment System (OPPS) Final Rule, Panacea Healthcare Solutions has created a comprehensive Final Rule Summary highlighting some of […]
The comprehensive diagnostic review includes analysis of CMS Price Transparency shoppable items and services to alert providers of risks and opportunities.
Designed for hospitals just starting on their consumer display and machine-readable file, this session will include an overview of the requirements, 10 things you need to know, data requirements, how […]
Panacea to Showcase Auditing Technology at the Annual HCCA Conference
/in Press Releases /by Panacea InsightsAttendees at Health Care Compliance Association’s 26th Annual Conference can visit Panacea’s virtual booth for the latest compliance resources.
Evaluation and Management (E&M) Split (or Shared) Visits – 2022 Summary of Changes
/in Expert Opinions /by Panacea InsightsThe 2022 Final Rule defines split (or shared) visits as evaluation and management (E&M) visits in the facility setting that are performed in part by both the physician and a non-physician practitioner (NPP) who are in the same group, in accordance with applicable laws and regulations.
Document Your Leftovers: The JW Modifier and How to Use It
/in Expert Opinions /by Panacea InsightsOn Jan. 1, 2017, the Centers for Medicare & Medicaid Services (CMS) and Medicare Administrative Contractors (MACs) began requiring the use of the JW modifier. The JW modifier is appended […]
Pricing Strategies. What’s Your Defense?
/in Price Transparency /by Panacea InsightsIn today’s era of intense public scrutiny on medical costs, what’s your pricing strategy? Does it pass the test of fairness and accuracy, without sacrificing revenue objectives? In this article, Panacea’s experts share their recommendations on where to start.
New Modifiers: Hospital Outpatient Billing for Injectable Self-Administered Drugs
/in Expert Opinions /by Panacea InsightsDo you and your team have a good process to readily identify and bill appropriately for self-administered drugs? The Centers for Medicare & Medicaid Services (CMS) has had a longstanding […]
What’s on Your 2021 OIG Compliance Greatest Hits List?
/in Auditing & Compliance, Expert Opinions /by Panacea InsightsCompliance plans are critical to making sure your organization is mitigating risk. The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) recommends that you audit […]
New ICD-10 Codes Create Clarity in Capturing COVID in 2021
/in Auditing & Compliance, Expert Opinions /by Panacea InsightsThe chaos and confusion fomented throughout the American healthcare industry by the continuing COVID-19 pandemic has been bad enough in of itself – but when coders found themselves unable to […]
Panacea Unveils Comprehensive Summary of 2021 OPPS Final Rule
/in Expert Opinions, Revenue Integrity /by Panacea InsightsFollowing the recent unveiling by federal officials of the 2021 Outpatient Prospective Payment System (OPPS) Final Rule, Panacea Healthcare Solutions has created a comprehensive Final Rule Summary highlighting some of […]
Panacea Announces No-Cost Diagnostic Review of Hospital Chargemaster ahead of CMS Final Rule Posting Deadline
/in News, Price Transparency /by Panacea InsightsThe comprehensive diagnostic review includes analysis of CMS Price Transparency shoppable items and services to alert providers of risks and opportunities.
Webinar: CMS Price Transparency – How to Comply with Consumer Display & Machine-Readable File Requirements
/in Price Transparency /by Panacea InsightsDesigned for hospitals just starting on their consumer display and machine-readable file, this session will include an overview of the requirements, 10 things you need to know, data requirements, how […]